Resistance to PSEN1-selective γ-secretase inhibitors in T-cell acute lymphoblastic leukemia
Charlien Vandersmissen(Universitair Ziekenhuis Leuven), Jan Cools(Universitair Ziekenhuis Leuven)
Cited by 0
Related Papers
The ability of sorafenib to inhibit oncogenic PDGFR and FLT3 mutants and overcome resistance to other small molecule inhibitors
|Haematologica|2007|93
Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia
|Blood|2019|63